is there an age limit for glp-1 use peaks in middle age, then drops at 65 Age and GLP-1 Medications: Clinical

Johnson & Johnson seeks first approval of nipocalimab to treat broadest population living with antibody positive generalized myasthenia gravis [press release]

doi:10.1001/jama.2021.3224 17Zafer M, Tavaglione F, Romero-Gmez M, Loomba R

So, one is aging related costs, you mentioned it already

doi:10.1007/s00125-008-1149-y Buteau J

Temperature accelerates two things: the growth rate of any bacteria that managed to enter through needle puncture, and the rate at which benzyl alcohol itself degrades

Widespread rollout and unprecedented research interest have offered ample opportunity for studies into the optimal vaccine regimen for protection